A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Thomas Jefferson University
Thomas Jefferson University
New York Medical College
BeOne Medicines
National Cancer Institute (NCI)
Nurix Therapeutics, Inc.
Verismo Therapeutics
National Cancer Institute (NCI)
Regeneron Pharmaceuticals
AbbVie
Henan Cancer Hospital
Genmab
International Extranodal Lymphoma Study Group (IELSG)
Calibr, a division of Scripps Research
Genmab
International Extranodal Lymphoma Study Group (IELSG)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Novartis
Vironexis Biotherapeutics Inc.
AbbVie
Ruijin Hospital
Ohio State University Comprehensive Cancer Center
Nurix Therapeutics, Inc.
M.D. Anderson Cancer Center
Cellectar Biosciences, Inc.
BeOne Medicines
MEI Pharma, Inc.
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Dana-Farber Cancer Institute
Massachusetts General Hospital
Galapagos NV
Beth Israel Deaconess Medical Center
Masonic Cancer Center, University of Minnesota
BeOne Medicines
University of Chicago
University of Washington
The First Affiliated Hospital with Nanjing Medical University
Eli Lilly and Company
ModeX Therapeutics, An OPKO Health Company
Institute of Hematology & Blood Diseases Hospital, China
Massachusetts General Hospital
Fred Hutchinson Cancer Center
University of Ulm
First Affiliated Hospital of Zhejiang University
Fudan University
Medical College of Wisconsin
Medical College of Wisconsin
BeOne Medicines
Ascentage Pharma Group Inc.
Dana-Farber Cancer Institute
Memorial Sloan Kettering Cancer Center